FendXLogo-GreenBG-1200w

MANAGEMENT

Executive Management

Dr. Carolyn Myers, MBA, PhD

President, Chief Executive Officer, Director

Dr. Carolyn Myers

Dr. Carolyn Myers, MBA, PhD
President, Chief Executive Officer and Director 

Dr. Carolyn Myers is an accomplished senior executive with extensive experience creating, growing, and leading healthcare businesses. Dr. Myers is currently CEO of FendX Technologies Inc. She is also a Principal of BioEnsemble LLC, where she works closely with numerous start-ups and small pharma companies to assist them in developing their business strategy and planning. Her previous executive positions include Vice President International Business Development and Alliance Management at Allergan PLC, President of Dey Laboratories and President of Mylan Technologies Inc. Prior to serving in these roles, Dr. Myers served in various management positions in sales and marketing at Pharmacia Corporation., now a part of Pfizer, Inc. Dr. Myers is also a director at Mayne Pharma Group Ltd. and Hyloris Pharmaceuticals SA, both publicly listed companies. She earned her PhD in genetics from the University of British Columbia and her MBA from Rutgers University.

Andrea Mulder, BPHE, MBA

Chief Operating Officer

Dr. Carolyn Myers

Andrea Mulder, BPHE, MBA
Chief Operating Officer

Andrea Mulder is an accomplished senior commercial healthcare executive with extensive sales and marketing experience leading launch strategies at leading pharmaceutical and biotechnology corporations in Canada.  Andrea Mulder is COO of FendX Technologies Inc. She has significant therapeutic knowledge across multiple therapeutic areas including infectious disease, immunology, neurology, respiratory and oncology and has been an active member of Global and Canadian leadership/ commercial teams at:  Eisai Canada, Ipsen, GlaxoSmithKline, Roche, Johnson and Johnson and Pfizer.  Andrea Mulder earned her degree at the University of Toronto in Health Sciences-Kinesiology and her EMBA in Global Leadership at the University of Fredericton, Canada.

Rose Zanic, CPA, CA

Chief Financial Officer

Dr. Carolyn Myers

Rose Zanic, CPA, CA
Chief Financial Officer

Rose Zanic has over 25 years’ of capital markets and corporate finance expertise. She is a self-employed corporate finance professional with significant experience advising Canadian public companies with financing, M&A transactions and providing public company administration. She previously spent 19 years with Wolverton Securities Ltd. where she was Senior Vice-President, Corporate Finance in charge of that firm’s corporate finance and syndication departments.

Ms. Zanic holds a CPA, CA designation and received a Bachelor of Commerce degree from the University of British Columbia. She currently is a director and/or officer of several Canadian publicly listed companies and is also a member of the TSX Venture Exchange BC Local Advisory Committee.

FendX Technologies Inc. (CSE: FNDX | OTCQB: FDXTF | FSE: E8D) – Innovative nanotechnology that reduces the spread of viruses and bacteria.

Quick contact
  • 2010 Winston Park Drive
    2nd Floor
    Oakville, Ontario, Canada
    L6H 5R7
    1-800-344-9868
  • info@fendxtech.com
The company
Follow us
Facebook Linkedin

REPELWRAP is a trademark of FendX Technologies Inc., 2023